IRLAB Therapeutics AB
STO:IRLAB A
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
IRLAB Therapeutics AB
STO:IRLAB A
|
SE |
|
Aena SME SA
MAD:AENA
|
ES |
|
Vialife SA
PAR:ALVIA
|
FR |
|
D
|
Delic Holdings Corp
CNSX:DELC
|
CA |
|
180 Life Sciences Corp
NASDAQ:ATNF
|
US |
|
M
|
MLRN Projects and Trade Ltd
TASE:MLRN
|
IL |
|
JW Life Science Corp
KRX:234080
|
KR |
|
Atlantic American Corp
NASDAQ:AAME
|
US |
|
T
|
Tony G Co-Investment Holdings Ltd
CNSX:TONY
|
CA |
|
F
|
Fermi Inc
NASDAQ:FRMI
|
US |
|
Gujarat Sidhee Cement Ltd
NSE:GSCLCEMENT
|
IN |
|
BOC Hong Kong Holdings Ltd
HKEX:2388
|
HK |
|
Payright Ltd
ASX:PYR
|
AU |
|
G
|
Guangdong Xinbao Electrical Appliances Holdings Co Ltd
SZSE:002705
|
CN |
|
Minna Padi Investama Sekuritas Tbk PT
IDX:PADI
|
ID |
Bankruptcy Probability
IRLAB Therapeutics AB's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
IRLAB Therapeutics AB Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SE |
|
IRLAB Therapeutics AB
STO:IRLAB A
|
132.5m SEK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
887.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
574.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
236.2B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
300.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
233.6B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
153.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
GlaxoSmithKline PLC
LSE:GSK
|
88.7B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
IRLAB Therapeutics AB's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, IRLAB Therapeutics AB has total debt of 26.4m SEK. This includes both short-term (26.4m SEK) and long-term (0 SEK) debt.
You can find a full breakdown on its Balance Sheet.
